72 Investment Holdings, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), 72 Investment Holdings, LLC reported 7 stock positions worth $39.8 million. Its top holding was Lenz Therapeutics (LENZ) at 44.2% of the portfolio, followed by Korro Bio (KRRO, 23.6%) and Alto Neuroscience (ANRO, 17.9%). Compared with Q1 2024, it reduced 1. The biggest sale was Turnstone Biologics (TSBX, shares −0%).
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $39.8M (Q2 2024)
- SEC Filing
- 0000902664-24-005144 ↗ filed Aug 14, 2024
Holdings Value
Holdings 7 stocks · $39.8M
| LENZ Lenz Therapeutics Inc. | 44.23% | 1,017,751 | $17.6M | No change |
| KRRO Korro Bio Inc. | 23.57% | 276,831 | $9.4M | No change |
| ANRO Alto Neuroscience Inc. | 17.94% | 667,778 | $7.1M | No change |
| PRAX Praxis Precision Medicines I | 6.85% | 65,933 | $2.7M | No change |
| TSBX Turnstone Biologics Corp. | 3.62% | 549,980 | $1.4M | Reduce 0.0% |
| CRBU Caribou Biosciences Inc. | 1.95% | 474,067 | $777K | No change |
| OMGAQ Omega Therapeutics Inc. | 1.84% | 352,941 | $731K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| TSBX Turnstone Biologics Corp. | Reduce 0.0% | 3.62% | +1.47 |
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |